The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?

by Wurm A.A., Tenen D.G., Behre G.
Published 2019

NF-?B/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia

by Gerloff, D., Grundler, R., Wurm, A.A., Brauer-Hartmann, D., Katzerke, C., Hartmann, J.-U., Madan, Vikas, Muller-Tidow, C., Duyster, J., Tenen, Daniel G., Niederwieser D., Behre G.
Published 2016

Disruption of the C/EBP? - MiR-182 balance impairs granulocytic differentiation

by Wurm, A.A, Zjablovskaja, P, Kardosova, M, Gerloff, D, Bräuer-Hartmann, D, Katzerke, C, Hartmann, J.-U, Benoukraf, T, Fricke, S, Hilger, N, Müller, A.-M, Bill, M, Schwind, S, Tenen, D.G, Niederwieser, D, Alberich-Jorda, M, Behre, G
Published 2020